Barinthus Biotherapeutics Competitors and Similar CompaniesClear all

Barinthus Biotherapeutics's competitors and similar companies include Mersana Therapeutics, Seagen, Dendreon and Legend Biotech.

	Barinthus Biotherapeutics Barinthus Biotherapeutics (formerly known as Vaccitech) is a T-cell immunotherapy company developing products to treat and prevent cancer and infectious diseases.	Mersana Therapeutics Mersana Therapeutics is a clinical-stage biotechnology company developing antibody-drug conjugate (ADC) platforms.	Seagen Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer.	Dendreon Dendreon Pharmaceuticals (formerly known as Activated Cell Therapy) is a biopharmaceutical company that engages in the development of immunotherapy.	Legend Biotech Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications.
Founding Date	Founding Date 2016	Founding Date 2005	Founding Date 1998	Founding Date 1992	Founding Date 2014
Type	Type Public	Type Public	Type Subsidiary	Type Subsidiary	Type Public
Tags	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy
Locations	Locations Oxford, GB HQ	Locations Cambridge, US HQ	Locations Bothell, US HQ Mississauga, CA Hørsholm, DK Rueil Malmaison, FR München, DE Milano, IT Schiphol, NL see more	Locations Seal Beach, US HQ Seattle, US Union City, US Tampa, US	Locations Somerset, US HQ Ghent, BE Nanjing, CN Hong Kong, HK Dublin, IE Piscataway, US
Employees	Employees 33	Employees 11033% increase	Employees 3,25622% increase	Employees 6131% decrease	Employees 2,90012% increase
Valuation ($)	Valuation ($) 57.2 m	Valuation ($) 250.3 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 8.4 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $40.5m (FY, 2024)	Revenue (est.) $2b (FY, 2022)	Revenue (est.) N/A	Revenue (est.) $1b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $410.1m (FY, 2022)	Cost of goods N/A	Cost of goods $408.1m (FY, 2025)
Gross profit	Gross profit $16k (FY, 2025)	Gross profit N/A	Gross profit $1.6b (FY, 2022)	Gross profit N/A	Gross profit $620.8m (FY, 2025)
Net income	Net income ($66.5m) (FY, 2025)	Net income ($69.2m) (FY, 2024)	Net income ($610.3m) (FY, 2022)	Net income N/A	Net income ($296.8m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 195.1m	Total funding raised $ 219.5m	Total funding raised $ 164m	Total funding raised N/A	Total funding raised $ 150.5m